Endovascular Today21 小时
Humacyte’s ATEV Results Presented From V007 Phase 3 AV Access Trial
Humacyte, Inc. recently announced the presentation of results from the V007 phase 3 clinical trial of the company’s acel ...
Endovascular Today22 小时
R3 Vascular Receives IDE Approval for ELITE-BTK Pivotal Trial of Magnitude Scaffold
November 13, 2024—R3 Vascular Inc. recently announced that the FDA granted investigational device exemption (IDE) approval to initiate the company’s ELITE-BTK pivotal trial of Magnitude, its ...